HM-43239 Uses, Dosage, Side Effects and more

HM-43239 is under investigation in clinical trial NCT03850574 (Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).

Attribute	Details
Trade Name	HM-43239
Generic	HM-43239
Type
Formula	C29H33ClN6
Weight	Average: 501.08 Monoisotopic: 500.2455228
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph